Two Sigma Securities’s SELLAS Life Sciences SLS Stock Holding History

Two Sigma Securities’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.1K	Sell	14,437 -42,668	-75%	-$191K	0.01%	1240
2025 Q4	$215K	Buy	+57,105	New	+$111K	0.03%	824
2025 Q2	–	Sell	-12,969	Closed	-$14K	–	2028
2025 Q1	$14K	Buy	+12,969	New	+$15.4K	﹤0.01%	1166
2024 Q1	–	Sell	-15,304	Closed	-$16.2K	–	3589
2023 Q4	$16.2K	Buy	+15,304	New	+$16.6K	﹤0.01%	2759
2023 Q1	–	Sell	-16,076	Closed	-$37.9K	–	3216
2022 Q4	$37.9K	Buy	+16,076	New	+$45.1K	﹤0.01%	2201
2019 Q3	–	Sell	-339	Closed	-$2K	–	2423
2019 Q2	$2K	Buy	339 +123	+57%	+$4.37K	﹤0.01%	2038
2019 Q1	$11K	Buy	+216	New	+$15K	﹤0.01%	1726
2018 Q4	–	Sell	-269	Closed	-$16K	–	2767
2018 Q3	$16K	Buy	+269	New	+$18.6K	﹤0.01%	2469
2018 Q1	–	Sell	-12	Closed	-$5K	–	2931
2017 Q4	$5K	Sell	12 -11	-48%	-$5.32K	﹤0.01%	1691
2017 Q3	$12K	Buy	+23	New	+$15.2K	﹤0.01%	862
2017 Q2	–	Sell	-9	Closed	-$8K	–	1147
2017 Q1	$8K	Buy	+9	New	+$14.9K	﹤0.01%	862

Other funds holding SLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Two Sigma Securities's SLS Position: Q1 2026 in Review

Two Sigma Securities reduced its SELLAS Life Sciences (SLS) stake by 75% in Q1 2026, selling an estimated $191K and leaving 14,437 shares worth $61.1K. The position accounts for 0.01% of the portfolio, ranked #1240.

Two Sigma Securities first reported a position in SLS in Q1 2017 and has held it in 11 quarters since. The position peaked at $215K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

Two Sigma Securities held 14,437 shares of SELLAS Life Sciences worth $61.1K as of Q1 2026.
Two Sigma Securities sold 42,668 SELLAS Life Sciences shares in Q1 2026, an estimated $191K.
SELLAS Life Sciences made up 0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1240 holding.
Two Sigma Securities first reported a position in SELLAS Life Sciences in Q1 2017 and has held it in 11 quarters since.
Two Sigma Securities's SELLAS Life Sciences position peaked at $215K in Q4 2025.
160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.